Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort.


Journal

Diabetes & metabolism
ISSN: 1878-1780
Titre abrégé: Diabetes Metab
Pays: France
ID NLM: 9607599

Informations de publication

Date de publication:
04 2020
Historique:
received: 20 03 2019
revised: 15 05 2019
accepted: 09 06 2019
pubmed: 19 6 2019
medline: 8 7 2021
entrez: 19 6 2019
Statut: ppublish

Résumé

In the D.E.S.I.R. cohort, higher consumption of dairy products was associated with lower incidence of hyperglycaemia, and dihydroceramide concentrations were higher in those who progressed to diabetes. Our aim here was to study the relationships between dairy consumption and concentrations of dihydroceramides and ceramides. In the D.E.S.I.R. cohort, men and women aged 30-65 years, volunteers from West-Central France, were included in a 9-year follow-up with examinations every 3 years, including food-frequency questionnaires. Two items concerned dairy products (cheese, other dairy products except cheese). At each examination, dihydroceramides and ceramides were determined by mass spectrometry in a cohort subset; in the present study, the 105 people who did not progress to type 2 diabetes were analyzed, as the disorder per se might be a confounding factor. Higher consumption of dairy products (except cheese) was associated with total plasma dihydroceramides during the follow-up, but only in women (P=0.01 for gender interaction). In fact, dihydroceramide levels were lower in women with high vs low consumption (P=0.03), and were significantly increased during follow-up (P=0.01) in low consumers only. There was also a trend for lower ceramides in women with high dairy (except cheese) intakes (P=0.08). Cheese was associated with dihydroceramide and ceramide changes during follow-up (P=0.04 for both), but no clear trend was evident in either low or high consumers. These results show that, in women, there is an inverse association between fresh dairy product consumption and predictive markers (dihydroceramides) of type 2 diabetes.

Identifiants

pubmed: 31212089
pii: S1262-3636(19)30093-X
doi: 10.1016/j.diabet.2019.06.002
pii:
doi:

Substances chimiques

Ceramides 0
dihydroceramide 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-149

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

F Fumeron (F)

Centre de Recherche des Cordeliers, Inserm UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France; Université de Paris, UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France. Electronic address: frederic.fumeron@inserm.fr.

A Nicolas (A)

Centre de Recherche des Cordeliers, Inserm UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France; Sorbonne Université, 15 rue de l'école de Médecine, 75006 Paris, France.

J-P Bastard (JP)

AP-HP, Biochemistry and Hormonology Department, Tenon Hospital, 4 Rue de la Chine, 75020 Paris, France.

S Fellahi (S)

AP-HP, Biochemistry and Hormonology Department, Tenon Hospital, 4 Rue de la Chine, 75020 Paris, France.

L Wigger (L)

Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

M Ibberson (M)

Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

C Cruciani-Guglielmacci (C)

Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université de Paris, 4 rue Marie-Andrée Lagroua Weill Hallé, 75013 Paris, France.

H Le Stunff (H)

UMR 9198 Institut des Neurosciences Paris Saclay (Neuro-PSI), Université Paris-Sud, Université Paris-Saclay, bâtiment 447, 91405 Orsay cedex, France.

G Velho (G)

Centre de Recherche des Cordeliers, Inserm UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France.

C Magnan (C)

Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université de Paris, 4 rue Marie-Andrée Lagroua Weill Hallé, 75013 Paris, France.

M Marre (M)

Centre de Recherche des Cordeliers, Inserm UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France; Université de Paris, UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France; Diabetology, Endocrinology, Nutrition, APHP - Bichat Hospital, 46 rue Henri Huchard, 75018 Paris, France.

B Balkau (B)

Centre for Research in Epidemiology and Population Health (CESP), INSERM, UMR-S 1018, University Paris-Sud, University Versailles Saint-Quentin, 16 av. Paul Vaillant Couturier 94800 Villejuif, France.

R Roussel (R)

Centre de Recherche des Cordeliers, Inserm UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France; Université de Paris, UMR-S 1138, 15 rue de l'école de Médecine, 75006 Paris, France; Diabetology, Endocrinology, Nutrition, APHP - Bichat Hospital, 46 rue Henri Huchard, 75018 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH